Code | 35916 | ||||||||||
MA number | EU/1/06/347/002 | ||||||||||
Product Form: | cps dur 30x25 mg (fľ. HDPE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 19.07.2006 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC SUTENT II-27_SK_FINAL_20Jan11_appr-SIDC (Gibala).pdf |
Safety feature | Yes |
Data update: | 11.10.2021 |